These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melanoma risk in individuals with clinically atypical nevi. Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ. Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717 [Abstract] [Full Text] [Related]
3. [The number and distribution of nevus cell nevi in patients with malignant melanoma]. Welkovich B, Landthaler M, Schmoeckel C, Braun-Falco O. Hautarzt; 1989 Oct; 40(10):630-5. PubMed ID: 2613517 [Abstract] [Full Text] [Related]
4. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Richtig E, Langmann G, Müllner K, Smolle J. Ophthalmologica; 2004 Oct; 218(2):111-4. PubMed ID: 15004500 [Abstract] [Full Text] [Related]
6. Ocular findings in patients with dysplastic nevus syndrome. An update. Rodriguez-Sains RS. Dermatol Clin; 1991 Oct; 9(4):723-8. PubMed ID: 1934647 [Abstract] [Full Text] [Related]
7. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis. Weis E, Shah CP, Lajous M, Shields JA, Shields CL. Ophthalmology; 2009 Mar; 116(3):536-543.e2. PubMed ID: 19167086 [Abstract] [Full Text] [Related]
8. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. Risser J, Pressley Z, Veledar E, Washington C, Chen SC. J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623 [Abstract] [Full Text] [Related]
9. Dysplastic nevi in relation to superficial spreading melanoma. Titus-Ernstoff L, Barnhill RL, Duray PH, Ernstoff MS, Kirkwood JM. Cancer Epidemiol Biomarkers Prev; 1993 Sep; 2(2):99-101. PubMed ID: 8467253 [Abstract] [Full Text] [Related]
10. [Connection between uveal melanoma and dysplastic naevus syndrome]. Hammer H, Tóth-Molnár E, Oláh J, Dobozy A. Magy Onkol; 2005 Sep; 49(1):15-8. PubMed ID: 15902328 [Abstract] [Full Text] [Related]
14. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi. Schneider JS, Moore DH, Sagebiel RW. Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695 [Abstract] [Full Text] [Related]
15. Risk associations of melanoma in a Southern European population: results of a case/control study. Nikolaou VA, Sypsa V, Stefanaki I, Gogas H, Papadopoulos O, Polydorou D, Plaka M, Tsoutsos D, Dimou A, Mourtzoukou E, Korfitis V, Hatziolou E, Antoniou C, Hatzakis A, Katsambas A, Stratigos AJ. Cancer Causes Control; 2008 Sep; 19(7):671-9. PubMed ID: 18307049 [Abstract] [Full Text] [Related]
16. Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects. Carli P, Balzi D, de Giorgi V, Massi D, Palli D, Chiarugi A, Nardini P, Giannotti B. Eur J Dermatol; 2003 Sep; 13(5):482-6. PubMed ID: 14693495 [Abstract] [Full Text] [Related]
17. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis? Tóth-Molnár E, Hammer H, Oláh J. Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638 [Abstract] [Full Text] [Related]
18. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma. Rokuhara S, Saida T, Oguchi M, Matsumoto K, Murase S, Oguchi S. J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952 [Abstract] [Full Text] [Related]
19. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases. Boyd AS, Shakhtour B, Shyr Y. J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467 [Abstract] [Full Text] [Related]